Your browser doesn't support javascript.
loading
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.
Eckstein, Olive S; Visser, Johannes; Rodriguez-Galindo, Carlos; Allen, Carl E.
Afiliación
  • Eckstein OS; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
  • Visser J; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Rodriguez-Galindo C; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom; and.
  • Allen CE; Department of Oncology and.
Blood ; 133(15): 1691-1694, 2019 04 11.
Article en En | MEDLINE | ID: mdl-30718231
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Histiocitosis de Células de Langerhans / Proteínas Proto-Oncogénicas B-raf Límite: Child / Humans Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Histiocitosis de Células de Langerhans / Proteínas Proto-Oncogénicas B-raf Límite: Child / Humans Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article